You are here

Award Data

For best search results, use the search terms first and then apply the filters

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 205181 - 205190 of 207731 results

    SBC: EARLYDIAGNOSTICS INC            Topic: 428

    Integrative analysis of multi-omics datasets is revolutionizing cancer research and patient care. To take advantage of the full breadth of CRDC’s petabyte-scale data, EarlyDx will seamlessly integrate its liquid biopsy cloud-computing platform with CRDC data repositories. Liquid biopsies provide a non-invasive approach for interrogating the genomic and epigenomic profiles of tumors. Co-analysis ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  2. Actigraphy Enhanced Clinical Chronic Lower Back Pain Management

    SBC: ARBOR MEDICAL INNOVATIONS LLC            Topic: 105

    ABSTRACTEffective management of patients with chronic low back pain requires accurate and reliable methods to measure the effects of treatment on both pain and function. Yet this presents a serious dilemma to clinicians, who must currently rely exclusively on retrospective self-report measures (e.g., questionnaires) to capture this information. These assessments are usually only completed each tim ...

    SBIR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
  3. Modeling the effects of non-linear magnetic spin wave dynamics on RF circuits in COMSOL

    SBC: METAMAGNETICS INC            Topic: SB162007

    Metamagnetics proposes to develop a set of computational models that captures the behavior of non-linear microwave magnetic components, such as frequency selective limiters (FSL) and signal to noise enhancers (SNE), and deploy it within COMSOL, a multiphysics equation-based solver. Metamagnetics additionally proposes to utilize outputs from these models to develop and deploy “black box” circui ...

    SBIR Phase II 2018 Department of DefenseDefense Advanced Research Projects Agency
  4. Rapid Identification of Pathogenic Bacteria in Blood causing Sepsis

    SBC: ISENSE, LLC            Topic: NIAID

    Sepsis is the leading cause of deaths in US hospitals contributing to or causing of all US hospital deaths and is the most expensive condition treated in US hospitals costing more than $ billion annually More than million blood culture bottles are produced annually with a market size greater than $ B in the US and EU alone The two year phase II period spanned February to F ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health

    SBC: CELLSIGHT TECHNOLOGIES, INC.            Topic: 396

    Immunotherapy has transformed cancer treatment, but therapy response remains low for certain tumor types. Despite the vital significance of immune activity within tumors, there are currently no non-invasive immunomonitoring methods for assessment of immune contexture and assessment of response to therapy. To address this urgent need, Cellsight Technologies is developing a PET agent specific for ac ...

    SBIR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health
  6. Advanced Synergistic Structures for Interceptor Kill Vehicles

    SBC: SAN DIEGO COMPOSITES, INC.            Topic: MDA09004

    As part of the Ballistic Missile Defense Review (BMDR) policy, the Missile Defense Agency (MDA) has enacted a Phased Adaptive Approach (PAA) for BMD interceptors over the next 10 years. Phase 4 of the PAA will include the deployment in 2020 of a land based Aegis missile to provide early intercept capability. MDA has identified several technology needs for meeting the next generation requirements ...

    SBIR Phase II 2011 Department of DefenseMissile Defense Agency
  7. Development of anti-sense oligonucleotides as a therapeutic for cancer pain through selective block of sodium channel pain targets

    SBC: QUELLTX INC            Topic: 102

    Project Summary: Development of anti-sense oligonucleotides as a therapeutic for cancer pain by selectively reducing sodium channel expression Effective treatment of cancer pain is a large unmet medical need, as opioids, the current standard of care lack efficacy and cause addiction. For end-of-life cancer patients and estrogen receptor- positive breast cancer patients with long life expectancy, m ...

    SBIR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health
  8. CUES: Cyber-mediated Usable Emotional Sensors: Phase 2 Proposal

    SBC: CARLEY TECHNOLOGIES, INC            Topic: N19AT024

    Cataclysmic changes in how we communicate in cyberspace are dramatically altering our society, allowing information to spread faster, farther, and with less assurance of its accuracy, and enabling groups to form and recruit members on-line to foster social divides. Organized social media manipulation has more than doubled since 2017, with at least 70 nation states employing computation assisted te ...

    STTR Phase II 2020 Department of DefenseNavy
  9. Endoscope development for the clinical use of near infrared fluorescence molecular probes in the GI tract

    SBC: VERAVANTI INC.            Topic: 102

    Minimally-invasive optical imaging is being advanced by molecular probes that enhance contrast using fluorescence. The applications in cancer imaging are very broad, ranging from early diagnosis of cancer to the guiding of interventions, such as biopsy. The high-sensitivity afforded by wide-field fluorescence imaging using scanning laser light is being developed for these broad applications. The p ...

    SBIR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health
  10. Liver Specific Manganese Based MRI Contrast Agent

    SBC: Reveal Pharmaceuticals, Inc.            Topic: 102

    Project Summary / Abstract Hepatocellular carcinoma (HCC) is the second most common cause of cancer death worldwide and HCC mortality is increasing at a faster rate than any other cancer. Metastatic liver disease occurs with greater frequency than HCC and is also associated with high mortality rates. There is a significant survival benefit associated with early detection of liver tumors. However, ...

    SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government